As of 2:30pm ET
| -4.76 / -4.45%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 124.00, with a high estimate of 163.00 and a low estimate of 87.00. The median estimate represents a +21.24% increase from the last price of 102.28.
The current consensus among 9 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.